resveratrol/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases interleukin-6 concentration
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“A significant reduction of IL-6 concentration was observed only in the patients receiving ≥500 mg/day dose of resveratrol (WMD = -1.89 pg/ml, 95% CI = -3.73 to -0.05, P = 0.04) with inter-study heterogeneity (I2 = 94.4%, P < 0.001).”
Quoted verbatim from Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- ≥500 mg/day (dose-stratified subgroup)
- Population
- Adults with inflammatory disease receiving ≥500 mg/day resveratrol (dose subgroup, one of 26 studies on IL-6 per Methods); the abstract does not report a significant result for the overall/lower-dose population.
Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.2021PMID:34303665Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Interleukin-6 concentration
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3R2HN600AF1TNCQAQK3CW34